Decreased serum fibroblast growth factor 19 level is a risk factor for type 1 diabetes

BACKGROUND: Increasing evidence suggests that fibroblast growth factor 19 (FGF19) is a regulator of glucose metabolism and may provide a new therapeutic target for type 1 diabetes (T1D). However, the clinical relevance of FGF19 in T1D remains unclear. In this study, we examined the relationship betw...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Jingyi, Tang, Yingxin, Liu, Hui, Li, Yanhua, Li, Xia, Huang, Gan, Xiao, Yang, Zhou, Zhiguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033349/
https://www.ncbi.nlm.nih.gov/pubmed/33842597
http://dx.doi.org/10.21037/atm-20-5203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033349/
https://www.ncbi.nlm.nih.gov/pubmed/33842597
http://dx.doi.org/10.21037/atm-20-5203

Ejemplares similares